Darwin Wealth Management LLC Acquires Shares of 199 Danaher Co. (NYSE:DHR)

Darwin Wealth Management LLC bought a new position in Danaher Co. (NYSE:DHR) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 199 shares of the conglomerate’s stock, valued at approximately $55,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Legal & General Group Plc increased its holdings in shares of Danaher by 2.4% in the 2nd quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate’s stock worth $1,490,112,000 after purchasing an additional 139,989 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Danaher by 2.6% in the second quarter. Dimensional Fund Advisors LP now owns 3,398,649 shares of the conglomerate’s stock worth $849,195,000 after acquiring an additional 85,081 shares during the period. Massachusetts Financial Services Co. MA grew its holdings in shares of Danaher by 22.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate’s stock worth $761,475,000 after acquiring an additional 563,546 shares during the period. Swedbank AB bought a new stake in shares of Danaher in the first quarter worth $676,545,000. Finally, Blair William & Co. IL grew its holdings in shares of Danaher by 0.9% in the second quarter. Blair William & Co. IL now owns 1,777,030 shares of the conglomerate’s stock worth $443,991,000 after acquiring an additional 15,766 shares during the period. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on DHR. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a report on Monday. Evercore ISI lifted their price objective on Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Barclays lowered their target price on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. Bank of America lifted their target price on Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a research report on Wednesday, July 24th. Finally, Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a research report on Thursday, October 31st. Six investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $287.16.

Insider Transactions at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at $1,130,374.44. This trade represents a 18.44 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 10.90% of the company’s stock.

Danaher Trading Up 1.0 %

Shares of DHR stock opened at $233.10 on Thursday. Danaher Co. has a 1 year low of $213.61 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The stock’s 50 day simple moving average is $259.67 and its two-hundred day simple moving average is $260.13. The company has a market cap of $168.36 billion, a PE ratio of 44.48, a price-to-earnings-growth ratio of 4.24 and a beta of 0.85.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the prior year, the business posted $2.02 earnings per share. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. Research analysts predict that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. Danaher’s payout ratio is 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.